Skip to main content
. 2021 May 21;8(7):1543–1556. doi: 10.1002/acn3.51370

FIGURE 2.

FIGURE 2

Schematic summary of major therapeutic agents being tested for the SCAs. Major agents that have been successful in preclinical disease models are summarized, including gene silencing strategies, neurotrophic agents, and ion channel modifiers. Current agents being tested in active clinical trials in the United States were identified from clinicaltrials.gov.